Creative Biolabs offers CellRapeutics™ cytotoxicity test for CAR-T cells.
CAR engrafted T cell or NK cell may be toxic to normal cells which also express some tumor associated antigens on cell surface, however, this possibility can be evaluated via cytotoxicity analysis. Meanwhile, as an efficient alternative strategy, we can also coexpress CARs with an appropriate suicide gene which can regulate this potential cytotoxicity, in order to kill the cancer cells without influencing the normal ones. Please contact us at any time. We are always here to assist you.
From immuno-oncology news website.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy product with the complete TCR complex without HLA matching dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE